48,528
edits
m (→Microscopic) |
m (re-order) |
||
Line 3: | Line 3: | ||
An introduction to dermatopathy is found in the ''[[dermatopathology]]'' article. Non-malignant disease is covered in the ''[[non-malignant skin disease]]'' article. | An introduction to dermatopathy is found in the ''[[dermatopathology]]'' article. Non-malignant disease is covered in the ''[[non-malignant skin disease]]'' article. | ||
=The Big Three= | =The Big Three malignant= | ||
==Basal cell carcinoma== | |||
===General=== | |||
*Very common. | |||
*Sun exposed skin. | |||
*Very rarely metastasizes - so rare... some don't think this is really a malignancy. | |||
====Clinical==== | |||
*Telangiectasias. | |||
*Raised pearly nodule. | |||
====As part of a syndrome==== | |||
*[[Nevoid basal cell carcinoma syndrome]] (NBCCS), AKA ''Gorlin syndrome''. | |||
*Bazex syndrome (X-linked).<ref>URL: [http://emedicine.medscape.com/article/1101146-diagnosis http://emedicine.medscape.com/article/1101146-diagnosis]. Accessed on: 6 May 2010.</ref> | |||
===Microscopic=== | |||
Features:<ref name=Ref_PBoD8_1180-1>{{Ref PBoD8|1180-1}}</ref> | |||
*Nest of hyperchromatic (i.e. blue) cells (similar in appearance to basal cells) with: | |||
**Palisading of cells at the edge of the cell nests. | |||
**Artefactual separation of cells (forming the nests) from the underlying stroma. | |||
Notes: | |||
*Palisading = the long axes of the cells are alined and the axes are perpendicular to the interface between the (basaloid cell) nests and stroma. | |||
*There are various subtypes: [http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970110-3 http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970110-3]. | |||
DDx: | |||
*[[Trichoepithelioma]] - no artefactual cleft.<ref name=Ref_PBoD8_1180-1>{{Ref PBoD8|1180-1}}</ref> | |||
==Squamous cell carcinoma== | ==Squamous cell carcinoma== | ||
{{Main|Squamous carcinoma}} | {{Main|Squamous carcinoma}} | ||
Line 45: | Line 72: | ||
*CK7 -ve. | *CK7 -ve. | ||
**Toker cells CK7 +ve.<ref name=pmid19601945>{{Cite journal | last1 = Nofech-Mozes | first1 = S. | last2 = Hanna | first2 = W. | title = Toker cells revisited. | journal = Breast J | volume = 15 | issue = 4 | pages = 394-8 | month = | year = | doi = 10.1111/j.1524-4741.2009.00743.x | PMID = 19601945 }}</ref> | **Toker cells CK7 +ve.<ref name=pmid19601945>{{Cite journal | last1 = Nofech-Mozes | first1 = S. | last2 = Hanna | first2 = W. | title = Toker cells revisited. | journal = Breast J | volume = 15 | issue = 4 | pages = 394-8 | month = | year = | doi = 10.1111/j.1524-4741.2009.00743.x | PMID = 19601945 }}</ref> | ||
==Melanoma== | ==Melanoma== | ||
Line 89: | Line 89: | ||
**[[Nuclear pseudoinclusions]] (like in ''papillary thyroid carcinoma''). | **[[Nuclear pseudoinclusions]] (like in ''papillary thyroid carcinoma''). | ||
= | =Less common malignant= | ||
==Merkel cell carcinoma== | ==Merkel cell carcinoma== | ||
*Abbreviated ''MCC''. | *Abbreviated ''MCC''. |
edits